Fully Automated System Transforms Pre-Analytical Handling of Urine Specimens

Urine specimens make up a substantial portion of a laboratory’s daily workload, yet essential pre-analytical steps such as aliquoting are often still done manually. These manual processes are time-consuming, prone to error, and limit efficiency as testing volumes grow. Now, a new fully automated platform addresses these challenges by streamlining the handling of urine specimens from start to finish.

Copan Diagnostics (Murrieta, CA, USA) has introduced UriVerse, an advanced system that automates key steps, including decapping, precise aliquoting, barcode labeling, and recapping of secondary tubes. Vision-guided technology identifies containers, performs de-capping without manual sorting, and transfers up to 10 mL into as many as nine secondary tubes.

Image: UriVerse automates decapping of specimen containers, precise aliquoting, and automatic labeling/recapping of secondary tubes (Photo courtesy of Copan Diagnostics)

The system eliminates manual pipetting and sorting with continuous, random-access loading, cup recognition, and fully integrated labeling and capping. By automating these processes, UriVerse improves traceability, reduces variability, and integrates seamlessly into existing laboratory workflows. UriVerse is designed to meet the demands of chemistry, toxicology, and other high-volume urine testing.

UriVerse is especially suited for laboratories facing increasing volume, staff shortages, and pressure for faster turnaround times. By reducing hands-on time and minimizing errors, the system supports greater efficiency and consistency in urine testing. Its ability to handle growing specimen volumes with accuracy makes it a valuable tool for modern laboratory operations. UriVerse is designed to fit easily into existing laboratory workflows.

"With UriVerse, we offer an efficient, accurate solution to help laboratories meet rising urine testing demands while reducing variability through automation of manual pre-analytical tasks," said Fabrizio Mazzocchi, CEO of Copan Diagnostics.

Related Links:
Copan Diagnostics